blue cross blue shield plans reverse course on glp-1 coverage Why is rolling back of weight loss drugs in Massachusetts BCBSM pulling back on GLP-1

doi: 10.5001/omj.2022.17 26 LeeIHAhnDJ

3 of 3: Exenatide (BYETTA, BYDUREON) Phonetic pronunciation: ex EN a tide / bye A tuh / by DUR ee on Mnemonic: X in a Tide (Pod) Year of release: 2005 Price range: $740$950 either formulation FDA-approved for: Type 2 diabetes Mechanism: GLP-1 receptor agonist Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none in a bubble The structure of - en atide GLP analogs is based on ex en din, a naturally occurring peptide derived from lizard venom

AmbioPharm Best for: Large-scale generic peptide APIs and contract manufacturing

Beautifully written prose